PG
BMY icon

Pendal Group’s Bristol-Myers Squibb BMY Stock Holding History

Pendal Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$631K Sell
8,767
-4,221
-32% -$318K 0.01% 345
2022
Q3 		$924K Buy
12,988
+344
+3% +$25K 0.01% 284
2022
Q2 		$974K Sell
12,644
-24,628
-66% -$1.88M 0.01% 279
2022
Q1 		$2.72M Hold
37,272
– – 0.02% 211
2021
Q4 		$2.32M Buy
+37,272
New +$2.19M 0.02% 226
2021
Q3 		– Sell
-15,829
Closed -$1.06M – 577
2021
Q2 		$1.06M Sell
15,829
-11,944
-43% -$779K 0.01% 332
2021
Q1 		$1.75M Sell
27,773
-6,406
-19% -$399K 0.02% 240
2020
Q4 		$2.12M Sell
34,179
-25,512
-43% -$1.57M 0.02% 211
2020
Q3 		$3.6M Buy
59,691
+32,877
+123% +$1.98M 0.04% 121
2020
Q2 		$1.58M Buy
26,814
+10,910
+69% +$653K 0.02% 200
2020
Q1 		$886K Sell
15,904
-47,174
-75% -$2.88M 0.02% 225
2019
Q4 		$4.05M Buy
63,078
+59,692
+1,763% +$3.42M 0.05% 148
2019
Q3 		$172K Sell
3,386
-223,613
-99% -$10.5M ﹤0.01% 419
2019
Q2 		$10.3M Sell
226,999
-142,040
-38% -$6.62M 0.14% 73
2019
Q1 		$17.6M Buy
369,039
+25,920
+8% +$1.29M 0.24% 62
2018
Q4 		$17.8M Buy
343,119
+166,187
+94% +$8.93M 0.28% 60
2018
Q3 		$11M Sell
176,932
-60,916
-26% -$3.61M 0.15% 84
2018
Q2 		$13.2M Buy
237,848
+43,663
+22% +$2.36M 0.17% 92
2018
Q1 		$12.3M Sell
194,185
-19,720
-9% -$1.27M 0.16% 90
2017
Q4 		$13.1M Buy
213,905
+49,551
+30% +$3.1M 0.17% 95
2017
Q3 		$10.5M Buy
164,354
+56,032
+52% +$3.27M 0.14% 118
2017
Q2 		$6.04M Buy
+108,322
New +$5.89M 0.09% 154

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Pendal Group's BMY Position: Q4 2022 in Review

Pendal Group reduced its Bristol-Myers Squibb (BMY) stake by 32% in Q4 2022, selling an estimated $318K and leaving 8,767 shares worth $631K. The position accounts for 0.01% of the portfolio, ranked #345.

Pendal Group first reported a position in BMY in Q2 2017 and has held it in 22 quarters since. The position peaked at $17.8M in Q4 2018. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Pendal Group held 8,767 shares of Bristol-Myers Squibb worth $631K as of Q4 2022.
  • Pendal Group sold 4,221 Bristol-Myers Squibb shares in Q4 2022, an estimated $318K.
  • Bristol-Myers Squibb made up 0.01% of Pendal Group's portfolio in Q4 2022, its #345 holding.
  • Pendal Group first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 22 quarters since.
  • Pendal Group's Bristol-Myers Squibb position peaked at $17.8M in Q4 2018.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.